835 related articles for article (PubMed ID: 28213269)
41. Protective effects of oxymatrine against lipopolysaccharide/D‑galactosamine‑induced acute liver failure through oxidative damage, via activation of Nrf2/HO‑1 and modulation of inflammatory TLR4‑signaling pathways.
Xu J; Li C; Li Z; Yang C; Lei L; Ren W; Su Y; Chen C
Mol Med Rep; 2018 Jan; 17(1):1907-1912. PubMed ID: 29138821
[TBL] [Abstract][Full Text] [Related]
42. Methyl 3,4-dihydroxybenzoate protects against d-galN/LPS-induced acute liver injury by inhibiting inflammation and apoptosis in mice.
Wang X; Wu L; Zhang Q; Li L; Xie Y; Wan X; Wu H; Xiang Y
J Pharm Pharmacol; 2019 Jul; 71(7):1082-1088. PubMed ID: 31032922
[TBL] [Abstract][Full Text] [Related]
43. Endotoxin tolerance ameliorates lipopolysaccharide/D-galactosamine-induced acute liver failure by negative regulation of the NF-κB/NLRP3 and activation of Nrf2/HO-1 via Sitr1.
Shi H; Xie X; Zheng S; Chen H; Liu C; Li S; Lu M
Int Immunopharmacol; 2024 May; 132():111994. PubMed ID: 38581992
[TBL] [Abstract][Full Text] [Related]
44. Modulation of the crosstalk between Keap1/Nrf2/HO-1 and NF-κB signaling pathways by Tomatidine protects against inflammation/oxidative stress-driven fulminant hepatic failure in mice.
Abdulaal WH; Omar UM; Zeyadi M; El-Agamy DS; Alhakamy NA; Ibrahim SRM; Almalki NAR; Asfour HZ; Al-Rabia MW; Mohamed GA; Elshal M
Int Immunopharmacol; 2024 Mar; 130():111732. PubMed ID: 38402834
[TBL] [Abstract][Full Text] [Related]
45. Costunolide protects lipopolysaccharide/d-galactosamine-induced acute liver injury in mice by inhibiting NF-κB signaling pathway.
Wang Y; Zhang X; Zhao L; Shi M; Wei Z; Yang Z; Guo C; Fu Y
J Surg Res; 2017 Dec; 220():40-45. PubMed ID: 29180209
[TBL] [Abstract][Full Text] [Related]
46. Pretreatment of lipopolysaccharide (LPS) ameliorates D-GalN/LPS induced acute liver failure through TLR4 signaling pathway.
Zhang S; Yang N; Ni S; Li W; Xu L; Dong P; Lu M
Int J Clin Exp Pathol; 2014; 7(10):6626-34. PubMed ID: 25400741
[TBL] [Abstract][Full Text] [Related]
47. Esculin prevents Lipopolysaccharide/D-Galactosamine-induced acute liver injury in mice.
Liu A; Shen Y; Du Y; Chen J; Pei F; Fu W; Qiao J
Microb Pathog; 2018 Dec; 125():418-422. PubMed ID: 30290266
[TBL] [Abstract][Full Text] [Related]
48. Zerumbone Protects against Carbon Tetrachloride (CCl
Wang M; Niu J; Ou L; Deng B; Wang Y; Li S
Molecules; 2019 May; 24(10):. PubMed ID: 31121820
[TBL] [Abstract][Full Text] [Related]
49. Protective effect of linarin against D-galactosamine and lipopolysaccharide-induced fulminant hepatic failure.
Kim SJ; Cho HI; Kim SJ; Park JH; Kim JS; Kim YH; Lee SK; Kwak JH; Lee SM
Eur J Pharmacol; 2014 Sep; 738():66-73. PubMed ID: 24877692
[TBL] [Abstract][Full Text] [Related]
50. Protective effect of SKLB010 against D-galactosamine/lipopolysaccharide-induced acute liver failure via nuclear factor-κB signaling pathway in macrophages.
Xie C; Jingjing W; Li X; Zeng F; Ma L; Li C; Wei Z; Peng A; Chen L
Int Immunopharmacol; 2014 Aug; 21(2):261-8. PubMed ID: 24861250
[TBL] [Abstract][Full Text] [Related]
51. Dioscin reduces lipopolysaccharide-induced inflammatory liver injury via regulating TLR4/MyD88 signal pathway.
Yao H; Hu C; Yin L; Tao X; Xu L; Qi Y; Han X; Xu Y; Zhao Y; Wang C; Peng J
Int Immunopharmacol; 2016 Jul; 36():132-141. PubMed ID: 27135544
[TBL] [Abstract][Full Text] [Related]
52. Beta-sitosterol and its derivatives repress lipopolysaccharide/d-galactosamine-induced acute hepatic injury by inhibiting the oxidation and inflammation in mice.
Yin Y; Liu X; Liu J; Cai E; Zhu H; Li H; Zhang L; Li P; Zhao Y
Bioorg Med Chem Lett; 2018 May; 28(9):1525-1533. PubMed ID: 29622518
[TBL] [Abstract][Full Text] [Related]
53. Role of α-lipoic acid in LPS/d-GalN induced fulminant hepatic failure in mice: studies on oxidative stress, inflammation and apoptosis.
Xia X; Su C; Fu J; Zhang P; Jiang X; Xu D; Hu L; Song E; Song Y
Int Immunopharmacol; 2014 Oct; 22(2):293-302. PubMed ID: 25046589
[TBL] [Abstract][Full Text] [Related]
54. Hepatoprotective Effects of Kaempferol-3-O-α-l-Arabinopyranosyl-7-O-α-l-Rhamnopyranoside on d-Galactosamine and Lipopolysaccharide Caused Hepatic Failure in Mice.
Dong L; Yin L; Quan H; Chu Y; Lu J
Molecules; 2017 Oct; 22(10):. PubMed ID: 29057809
[TBL] [Abstract][Full Text] [Related]
55. Mycophenolate mofetil attenuates concanavalin A-induced acute liver injury through modulation of TLR4/NF-κB and Nrf2/HO-1 pathways.
Serrya MS; Zaghloul MS
Pharmacol Rep; 2020 Aug; 72(4):945-955. PubMed ID: 32048261
[TBL] [Abstract][Full Text] [Related]
56. Protective Role of 4-Octyl Itaconate in Murine LPS/D-GalN-Induced Acute Liver Failure via Inhibiting Inflammation, Oxidative Stress, and Apoptosis.
Li R; Yang W; Yin Y; Zhang P; Wang Y; Tao K
Oxid Med Cell Longev; 2021; 2021():9932099. PubMed ID: 34457120
[TBL] [Abstract][Full Text] [Related]
57. Scoparone attenuates D-galactosamine/lipopolysaccharide-induced fulminant hepatic failure through inhibition of toll-like receptor 4 signaling in mice.
Kang JW; Kim DW; Choi JS; Kim YS; Lee SM
Food Chem Toxicol; 2013 Jul; 57():132-9. PubMed ID: 23535186
[TBL] [Abstract][Full Text] [Related]
58. Hepatocyte-Conditional Knockout of Phosphatidylethanolamine Binding Protein 4 Aggravated LPS/D-GalN-Induced Acute Liver Injury
Qu XQ; Chen QF; Shi QQ; Luo QQ; Zheng SY; Li YH; Bai LY; Gan S; Zhou XY
Front Immunol; 2022; 13():901566. PubMed ID: 35874667
[TBL] [Abstract][Full Text] [Related]
59. Salvage effect of E5564, Toll-like receptor 4 antagonist on d-galactosamine and lipopolysaccharide-induced acute liver failure in rats.
Kitazawa T; Tsujimoto T; Kawaratani H; Fukui H
J Gastroenterol Hepatol; 2010 May; 25(5):1009-12. PubMed ID: 20546456
[TBL] [Abstract][Full Text] [Related]
60. Geraniol protects against lipopolysaccharide and D-galactosamine-induced fulminant hepatic failure by activating PPARγ.
Li Y; Wang N; Jiang Y
Microb Pathog; 2019 Mar; 128():7-12. PubMed ID: 30550845
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
